Venture Round - SetPoint Medical

Venture Round - SetPoint Medical

Investment Firm

Overview

SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.

Announced Date

Jan 27, 2021

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

New Enterprise Associates

New Enterprise Associates

New Enterprise Associates is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and venture firm.

Citta Capital

Citta Capital

Citta Capital is a convertible_note and early_stage_venture and seed and venture firm.

Participant Investors

11

Investor Name
Participant InvestorAction Potential Venture Capital
Participant InvestorBoston Scientific
Participant InvestorMorgenthaler Ventures
Participant InvestorNew Enterprise Associates
Participant InvestorCITA Investissement

Round Details and Background

SetPoint Medical raised $64000000 on 2021-01-27 in Venture Round

SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.

Company Funding History

12

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 26, 2009
Debt Financing - SetPoint Medical
-4.0M
Oct 19, 2010
Venture Round - SetPoint Medical
-5.0M
Apr 13, 2012
Debt Financing - SetPoint Medical
-3.3M
Aug 08, 2013
Series C - SetPoint Medical
7-27.0M

Recent Activity

There is no recent news or activity for this profile.